--Rayonier Keeps Quarterly Dividend at $0.285 per Share, Payable Sept. 30 to Shareholders as of Sept. 16-February 2024-www.financetom.com

--Rayonier Keeps Quarterly Dividend at $0.285 per Share, Payable Sept. 30 to Shareholders as of Sept. 16

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

--Rayonier Keeps Quarterly Dividend at $0.285 per Share, Payable Sept. 30 to Shareholders as of Sept. 16

Jul 22, 2024 6:52 AM

09:26 AM EDT, 07/22/2024 (MT Newswires) --

Price: 29.36, Change: +0.08, Percent Change: +0.27

Previous page： BRIEF-Teledyne To Acquire Micropac Next page： BRIEF-Tokyo Lifestyle Announces Joint Venture With Crossing Limited To Expand Into Trading Card Retail Business

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

BRIEF-Teledyne To Acquire Micropac

Nov 4, 2024

Nov 4 (Reuters) - Micropac Industries Inc ( MPAD ): * TELEDYNE TO ACQUIRE MICROPAC * MICROPAC INDUSTRIES INC ( MPAD ) - TELEDYNE TO ACQUIRE MICROPAC FOR $20.00 PER SHARE * MICROPAC INDUSTRIES INC ( MPAD ) - TRANSACTION VALUES MICROPAC AT APPROXIMATELY $57.3 MILLION Source text: Further company coverage: ...

BRIEF-Tokyo Lifestyle Announces Joint Venture With Crossing Limited To Expand Into Trading Card Retail Business

Nov 4, 2024

Nov 4 (Reuters) - Tokyo Lifestyle Co Ltd ( TKLF ): * TOKYO LIFESTYLE CO., LTD. ( TKLF ) ANNOUNCES JOINT VENTURE WITH CROSSING LIMITED TO EXPAND INTO TRADING CARD RETAIL BUSINESS * TOKYO LIFESTYLE CO LTD ( TKLF ) - ENTERS 5-YEAR AGREEMENT WITH CROSSING LIMITED * TOKYO LIFESTYLE CO LTD ( TKLF ) - CO AND CROSSING LIMITED...

BRIEF-Boston Scientific Announces Agreement To Acquire Cortex

Nov 4, 2024

Nov 4 (Reuters) - Boston Scientific Corp ( BSX ): * BOSTON SCIENTIFIC ANNOUNCES AGREEMENT TO ACQUIRE CORTEX, INC. * BOSTON SCIENTIFIC CORP ( BSX ): SPECIFIC TERMS OF TRANSACTION HAVE NOT BEEN DISCLOSED. * BOSTON SCIENTIFIC CORP ( BSX ) - TRANSACTION EXPECTED TO BE SLIGHTLY DILUTIVE ON GAAP BASIS IN 2025 * BOSTON SCIENTIFIC CORP ( BSX )...

What's Going On With Journey Medical Stock Today?

Nov 4, 2024

Journey Medical ( DERM ) shares are trading higher Monday after the company announced the U.S. Food and Drug Administration approved its Emrosi drug for the treatment of rosacea. What Happened: The FDA has approved Journey Medical’s Emrosi, formerly known as DFD-29, for the treatment of inflammatory lesions of rosacea in adults. The approval was supported by positive data from...